Related Experiment Videos
Pneumocystis jirovecii multilocus gene sequencing: findings and implications
Olga Matos1, Francisco Esteves
1Unidade de Protozoários Oportunistas/VIH e Outras Protozooses, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal. omatos@ihmt.unl.pt
Future Microbiology
|August 21, 2010
Summary
Multilocus genotyping reveals genetic diversity in Pneumocystis jirovecii, suggesting recombination and genotypes linked to Pneumocystis pneumonia severity. This aids understanding of PcP epidemiology and patient outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Molecular Epidemiology
Background:
- Pneumocystis jirovecii pneumonia (PcP) is a significant respiratory illness in immunocompromised individuals, particularly those with HIV.
- P. jirovecii has also been identified in immunocompetent individuals, indicating a broader host range.
- Understanding the genetic diversity of P. jirovecii is crucial for its epidemiology and clinical impact.
Purpose of the Study:
- To review the application of multilocus genotyping in studying P. jirovecii genetic diversity.
- To discuss epidemiological and clinical parameters associated with P. jirovecii genotypes.
- To highlight key findings from multilocus typing studies.
Main Methods:
- Multilocus genotyping analysis of P. jirovecii.
- Analysis of genetic diversity, epidemiological data, and clinical parameters.
- Review of existing multilocus typing studies.
Main Results:
- Multilocus typing reveals significant genetic diversity of P. jirovecii, with stable and ubiquitous genotypes.
- P. jirovecii infections are not strictly clonal, and recombination between genotypes is suggested.
- Specific P. jirovecii multilocus genotypes may correlate with PcP severity.
Conclusions:
- P. jirovecii infections contribute to a common human reservoir.
- Genetic characterization of P. jirovecii is essential for understanding drug resistance and PcP outcomes.
- Suitable genetic targets (CYB, DHFR, DHPS, mtLSU rRNA, SOD, ITS) are identified for future epidemiological studies.
Related Concept Videos
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:29Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...